This book provides a clear and concise summary of the workshop on Methods in Cancer Research held in Lunteren, The Netherlands, on 24 and 25 April 1978, and is the first of a series on Applied Methods in Oncology.
The first part is devoted to the clinical pharmacology of methotrexate, and it is good to see that the important role of "low dose" methotrexate has not been forgotten amidst the current enthusiasm for "high dose" therapy. There are concise reviews of the current methods of measuring methotrexate in biological fluids and attempts to relate toxicity to clinical and kinetic parameters are well covered. This logically leads to the problematic area of prevention of toxicity, and animal and human studies of thymidine and carboxypeptidase GI rescue are presented.
The second half attempts to review, of necessity briefly, the clinical pharmacology of many of the common antitumour agents, including adriamycin, bleomycin, vinca alkaloids and c68 platinum, with reference also to the newer derivatives of these established agents currently undergoing evaluation. Emphasis is again put on the measurement of the agents and their metabolites.
Each half is concluded with a summary of the discussion which followed the presentation of the papers. The discussion following the papers on methotrexate provides further useful information; that following the second half adds little to the book.
Over the past few years we have certainly come to appreciate the usefulness of monitoring serum levels of methotrexate, and to enable the safe use of all cytotoxics, knowledge of their pharmacokinetic properties is now an established requirement. This volume will certainly provide good reading material for those wishing to This addition to the established IARC series brings together data on 17 N-nitroso compounds and some of their derivatives. In the preamble to this volume the guiding criteria for the evaluation of carcinogenic risk to humans are stated, and the importance of quantitative data is emphasized.
The monographs themselves cover data (which in the case of biological studies are extensive and well documented) on: physical and chemical properties; industrial production and uses; occurrence and analysis; carcinogenicity, embryogenicity and teratogenicity in animals: mutagenicity and shortterm screening tests; toxicity and metabolism. Each monograph ends with an assessment of the likely human exposure and an evaluation of the carcinogenic risk presented to humans. Of the 17 compounds examined, it is concluded that 13 contribute to low-level exposure of the general population. While no epidemiological or other direct evidence exists to link N-nitroso compounds with cancer incidence in man, the IARC working group considers that for 15 compounds there is sufficient evidence of carcinogenicity in animals, and recommends that they should be regarded as carcinogenic in man.
This book contains a wealth of diverse data and should prove useful to workers in the fields of nitrosamine carcinogenesis and cancer epidemiology. The publication of the first volume of this series in 1972 was the result of an increase in the interest in chemical carcinogenesis, and a confidence that the advances in epidemiology and laboratory studies could have a wide importance to human affairs. These volumes have been a splendid success, and this one, dealing with the polychlorinated and polybrominated biphenyls, shows the great strength of the IARC approach. These compounds are widespread in the environment and are found in human tissue. Since the accidental contamination of rice in Japan, and the inadvertent mixing of PBBs with animal feed in Michigan, there has been a great deal of debate about their use. Yet it has always been difficult to obtain facts. The scientific community did not always play a proper role in informing the public, and some public statements made by scientists were ill advised (see Nature, 276, 205, 1978 This book is a series of short papers on various aspects of carcinoma of the colon. It has 4 sub-sections: epidemiology, experimental approaches, diagnosis and therapy.
In general, the work will be of more interest to practising clinicians than to workers in the experimental field, as the main thrust of the volume is at the clinical level, the experimental section being relatively short.
It suffers from the usual defects of multiauthorship in that the value of the various contributions is unevenly distributed. In addition, the standard of translation of several articles from German authors leaves much to be desired. Indeed, I felt after reading some of them that the translation was so poor as to have obscured the authors' intentions. Nevertheless, there is no doubt that many of the papers are by outstanding authors, reviewing their subjects as they see them at the moment. This results in an upto-date and authoritative summary of many aspects of carcinoma of the colon, and although no ideas are presented which have not been published elsewhere, the book contains much material of value to any clinician working with carcinoma of the large bowel. I particularly enjoyed Hill's contribution on Epidemiology and Etiology of Colon Cancer, although in the table of contents it is said to be on "Epiodemiology", which, unfortunately, is typical of a number of similar type-setting errors.
Contributions on the genetic aspects of colonic cancer by Dr McConnell, on early diagnosis by Dr Friihmorgen and by Dr Roschke, and a well-illustrated dissertation on pathological classification by Dr N. M Gibbs were particularly commendable.
In summary, this is a book of mixed quality with some excellent articles which are well worth reading, but is seriously flawed by the quality of the translation and printing, in which a number of very significant errors have been introduced. For example, on page 2, it is stated that ". . . cancer or the rectum when judged at the lower 4cm of the colon has quite a different epidemiologic pattern than colon cancer", which I have taken to be a misprint for ". . . cancer of the rectum, when judged at the lower 14 cm of the bowel, has a quite different epidemiologic pattern from colon cancer".
If In 1974, a working group (of a few of us who were involved) was convened by the Agency to attempt to evaluate the risk of vinyl chloride carcinogenicity to man. Before then, the permissible level of vinyl chloride exposure was of the order of 100 parts/106 or
